Ocular Hypertension Clinical Trials

A listing of Ocular Hypertension medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

 

Arizona

UPDATED

Chandler Arizona 85225

A Phase 2 clinical study for patients with Ocular Hypertension or Open-Angle Glaucoma

UPDATED

Phoenix Arizona 85050

A Phase 2 clinical study for patients with Ocular Hypertension or Open-Angle Glaucoma

Arkansas

Fayetteville Arkansas 72704

A clinical trial to evaluate treatments using OTX-TP and Timolol for patients with Glaucoma or Ocular Hypertension

California

UPDATED

Torrance California 90505

A Phase 2 clinical study for patients with Ocular Hypertension or Open-Angle Glaucoma

Artesia California 90701

A clinical research study for the treatment of Open Angle Glaucoma or Ocular Hypertension

Newport Beach California 92663

Patients are needed to participate in a clinical research study evaluating Test-Brinzolamide 1% Ophthalmic suspension and Reference-Brinzolamide 1% Ophthalmic suspension for the treatment of Glaucoma

Petaluma California 94954

A clinical research study for the treatment of Open Angle Glaucoma or Ocular Hypertension

San Francisco California 94105

A clinical study for patients with Primary Open Angle Glaucoma, Ocular Hypertension, Pseudo-Exfoliative Glaucoma or Pigment Dispersion Glaucoma

View More ▼

Torrance California

Patients are needed to participate in a clinical research study evaluating Bimatoprost sustained-release, Sham, Timolol and Timolol Vehicle (placebo) for the treatment of Glaucoma, Open-Angle or Ocular Hypertension

Connecticut

New Haven Connecticut 06510

A clinical research study of Sensimed Triggersfish® for the treatment of Ocular Hypertension

Florida

UPDATED

Cape Coral Florida 33904

A Phase 2 clinical study for patients with Ocular Hypertension or Open-Angle Glaucoma

UPDATED

Fort Myers Florida 33901

A Phase 2 clinical study for patients with Ocular Hypertension or Open-Angle Glaucoma

Largo Florida 33773

Patients are needed to participate in a clinical research study evaluating Test-Brinzolamide 1% Ophthalmic suspension and Reference-Brinzolamide 1% Ophthalmic suspension for the treatment of Glaucoma

Miami Florida 33144

Patients are needed to participate in a clinical research study evaluating Test-Brinzolamide 1% Ophthalmic suspension and Reference-Brinzolamide 1% Ophthalmic suspension for the treatment of Glaucoma

Georgia

Morrow Georgia 30260

A clinical research study for the treatment of Open Angle Glaucoma or Ocular Hypertension

Morrow Georgia 30260

Patients are needed to participate in a clinical research study evaluating Test-Brinzolamide 1% Ophthalmic suspension and Reference-Brinzolamide 1% Ophthalmic suspension for the treatment of Glaucoma

Roswell Georgia 30076

Patients are needed to participate in a clinical research study evaluating Test-Brinzolamide 1% Ophthalmic suspension and Reference-Brinzolamide 1% Ophthalmic suspension for the treatment of Glaucoma

Indiana

UPDATED

Indianapolis Indiana 46202

A Phase 2 clinical study for patients with Ocular Hypertension or Open-Angle Glaucoma

Kansas

Shawnee Mission Kansas 66204

Patients are needed to participate in a clinical research study evaluating Test-Brinzolamide 1% Ophthalmic suspension and Reference-Brinzolamide 1% Ophthalmic suspension for the treatment of Glaucoma

Kentucky

UPDATED

Edgewood Kentucky 41017

A Phase 2 clinical study for patients with Ocular Hypertension or Open-Angle Glaucoma

Louisville Kentucky 40217

A clinical research study for the treatment of Open Angle Glaucoma or Ocular Hypertension

Michigan

UPDATED

St. Joseph Michigan 49085

A Phase 2 clinical study for patients with Ocular Hypertension or Open-Angle Glaucoma

Minnesota

UPDATED

Bloomington Minnesota 55420

A Phase 2 clinical study for patients with Ocular Hypertension or Open-Angle Glaucoma

Missouri

UPDATED

St. Louis Missouri 63131

A Phase 2 clinical study for patients with Ocular Hypertension or Open-Angle Glaucoma

UPDATED

Washington Missouri 63090

A Phase 2 clinical study for patients with Ocular Hypertension or Open-Angle Glaucoma

St. Louis Missouri 63131

Patients are needed to participate in a clinical research study evaluating Test-Brinzolamide 1% Ophthalmic suspension and Reference-Brinzolamide 1% Ophthalmic suspension for the treatment of Glaucoma

Nevada

UPDATED

Las Vegas Nevada 89148

A Phase 2 clinical study for patients with Ocular Hypertension or Open-Angle Glaucoma

Henderson Nevada 89074

Patients are needed to participate in a clinical research study evaluating Test-Brinzolamide 1% Ophthalmic suspension and Reference-Brinzolamide 1% Ophthalmic suspension for the treatment of Glaucoma

New Jersey

Bedminster New Jersey 07921

A Phase 3 clinical study for patients with Ocular Hypertension. or Glaucoma

New York

UPDATED

Lynbrook New York 11563

A Phase 2 clinical study for patients with Ocular Hypertension or Open-Angle Glaucoma

UPDATED

Slingerlands New York 12159

A Phase 2 clinical study for patients with Ocular Hypertension or Open-Angle Glaucoma

North Carolina

High Point North Carolina 27262

Patients are needed to participate in a clinical research study of Combigan BID and Simbrinza TID to evaluate Glaucoma or Ocular Hypertension

Research Triangle Park North Carolina 27709

Patients are needed to participate in a clinical research study evaluating ENV515 Travoprost XR and TRAVATAN Z for the treatment of Glaucoma and Ocular Hypertension

Pennsylvania

UPDATED

Philadelphia Pennsylvania 19107

A Phase 2 clinical study for patients with Ocular Hypertension or Open-Angle Glaucoma

UPDATED

Philadelphia Pennsylvania 19148

A Phase 2 clinical study for patients with Ocular Hypertension or Open-Angle Glaucoma

South Carolina

Goose Creek South Carolina 29445

A clinical trial to evaluate treatments using POLAT-001 and Latanoprost ophthalmic solution for patients with Glaucoma

Tennessee

UPDATED

Maryville Tennessee 37803

A Phase 2 clinical study for patients with Ocular Hypertension or Open-Angle Glaucoma

UPDATED

Memphis Tennessee 38119

A Phase 1 clinical study for patients with Open Angle Glaucoma or Ocular Hypertension (SAR366234 )

UPDATED

Memphis Tennessee 38119

A Phase 2 clinical study for patients with Ocular Hypertension or Open-Angle Glaucoma

Texas

Austin Texas

A Phase 3 clinical study for patients with Open-Angle Glaucoma or Ocular Hypertension

Austin Texas 78731

Patients are needed to participate in a clinical research study evaluating Test-Brinzolamide 1% Ophthalmic suspension and Reference-Brinzolamide 1% Ophthalmic suspension for the treatment of Glaucoma

Fort Worth Texas 76134

A Phase 4 clinical study for patients with Open-Angle Glaucoma or Ocular Hypertension

San Antonio Texas 78229

A clinical trial to evaluate treatments using Open angle glaucoma - iDropper device for patients with Glaucoma, Open-Angle

San Antonio Texas 78240

Patients are needed to participate in a clinical research study evaluating Test-Brinzolamide 1% Ophthalmic suspension and Reference-Brinzolamide 1% Ophthalmic suspension for the treatment of Glaucoma

Washington

Bellevue Washington

Patients are needed to participate in a clinical research study evaluating VS101 Insert Dose A, VS101 Insert Dose B, VS101 Insert Dose C and Latanoprost 0.005% eye drops for the treatment of Open Angle Glaucoma or Ocular Hypertension

Armenia

Yerevan 375108

A Phase 4 clinical study for patients with Primary Open Angle Glaucoma (POAG)

Yerevan 0001

Patients are needed to participate in a clinical research study evaluating iStent inject and Travoprost for the treatment of Open-angle Glaucoma

Australia

Melbourne Victoria

A Phase 3 clinical study for patients with Open-Angle Glaucoma or Ocular Hypertension

Bulgaria

Sofia 1408

Patients are needed to participate in a clinical research study of CF101 and Placebo to evaluate Ocular Hypertension or Glaucoma

Sofia 1527

Patients are needed to participate in a clinical research study of CF101 and Placebo to evaluate Ocular Hypertension or Glaucoma